9 Results for "

DHPG

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "DHPG" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-12598A
CAS No.: 146255-66-5
Purity:  99.65%
Synonyms: (RS)-3,5-DHPG
Target:  

mGluR

Research Areas:  

Neurological Disease

DHPG is the agonist for mGluR 1/5 (EC50 for mGluR 1 is 60 nM) that activates the phospholipase C (PLC) pathway, and leads ultimately to the activation of protein kinase C (PKC) .
loading...
    loading...
Cat. No.: HY-12598
CAS No.: 162870-29-3
Purity:  ≥99.0%
Target:  

mGluR

Research Areas:  

Neurological Disease

(S)-3,5-DHPG is a weak, but selective group I metabotropic glutamate receptors (mGluRs) agonist with Ki values of 0.9 μM and 3.9 μM for mGluR1a and mGluR5a, respectively . (S)-3,5-DHPG exhibits anxiolytic activity in rats subjected to hypoxia .
loading...
    loading...
Cat. No.: HY-103564
CAS No.: 37804-11-8
Purity:  ≥99.0%
Target:  

mGluR

Research Areas:  

Neurological Disease

ACDPP is a specific mGluR5 antagonist. ACDPP partially bolcks the increase of fragile X mental retardation protein (FMRP) caused by DHPG (HY-12598A) (group I mGluR Agonist) .
loading...
    loading...
Cat. No.: HY-103566
CAS No.: 338736-46-2
Purity:  99.81%
LY456236 is a selective, non-competitive and orally active antagonist of glutamate receptor 1 (mGlu1), which can inhibit phosphatidylinositol hydrolysis with an IC50 of 0.145 μM. LY456236 can also inhibit EGFR, with an IC50 of 0.918 μM. LY456236 blocks cell proliferation by inhibiting the MAPK pathway, reversing the anti-apoptotic effect of DHPG (HY-12598A). LY456236 can be used in epilepsy research .
loading...
    loading...
Cat. No.: HY-12598AR
CAS No.: 146255-66-5
Synonyms: (RS)-3,5-DHPG (Standard)
Research Areas:  

Neurological Disease

DHPG (Standard) is the analytical standard of DHPG. This product is intended for research and analytical applications. DHPG is the agonist for mGluR 1/5 (EC50 for mGluR 1 is 60 nM) that activates the phospholipase C (PLC) pathway, and leads ultimately to the activation of protein kinase C (PKC) .
loading...
    loading...
Cat. No.: HY-119282
CAS No.: 453566-30-8
Target:  

mGluR

Research Areas:  

Neurological Disease

AZD6538 is a potent, selective and brain penetrant mGluR5 negative allosteric modulator. AZD6538 inhibits DHPG (HY-12598A)-stimulated intracellular Ca2+ release in HEK cells expressing rat or human mGluR5, with IC50 values of 3.2 and 13.4 nM for rat mGluR5 and human mGluR5, respectively. AZD6538 can be used for the research of neuropathic pain .
loading...
    loading...
Cat. No.: HY-141832
CAS No.: 1261171-52-1
Target:  

mGluR

Research Areas:  

Neurological Disease

mGluR5 modulator 1 is a mGluR5 positive allosteric modulator. mGluR5 modulator 1 can be used for the research of the schizophrenia and cognitive impairments .
loading...
    loading...
Cat. No.: HY-103566R
CAS No.: 338736-46-2
LY456236 (Standard) is the analytical standard of LY456236 (HY-103566). This product is intended for research and analytical applications. LY456236 is a selective, non-competitive and orally active antagonist of glutamate receptor 1 (mGlu1), which can inhibit phosphatidylinositol hydrolysis with an IC50 of 0.145 μM. LY456236 can also inhibit EGFR, with an IC50 of 0.918 μM. LY456236 has anticonvulsant effects and blocks cell proliferation by inhibiting the MAPK pathway, reversing the anti-apoptotic effect of DHPG (HY-12598A). LY456236 can be used in epilepsy research .
loading...
    loading...
Cat. No.: HY-103566A
CAS No.: 338738-57-1
Research Areas:  

Neurological Disease

LY456236 free base is a selective, non-competitive and orally active antagonist of glutamate receptor 1 (mGlu1), which can inhibit phosphatidylinositol hydrolysis with an IC50 of 0.145 μM. LY456236 free base can also inhibit EGFR, with an IC50 of 0.918 μM. LY456236 free base blocks cell proliferation by inhibiting the MAPK pathway, reversing the anti-apoptotic effect of DHPG (HY-12598A). LY456236 free base can be used in epilepsy research .
loading...
    loading...